Print

VRC 605

NCT03015181

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases (NIAID)
VRC-HIVMAB075-00-AB
Healthy adults
RandD/trials/Lists/ClinicalTrialsList
12/1/2018
VRC07-523LS antibody
1mg/kg IV on Day 0; Group 2:5mg/kg IV on Day 0 5mg/kg SC on Day 0; Group 6: 5mg/kg SC on Day 0, Week 12 & Week 24 20mg/kg IV on Day 0; Group 7: 20mg/kg IV on Day 0, Week 12 & Week 24 40mg/kg IV on Day 0